These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 18551073)

  • 21. Pharmacodynamics of rituximab in kidney transplantation.
    Genberg H; Hansson A; Wernerson A; Wennberg L; Tydén G
    Transplantation; 2007 Dec; 84(12 Suppl):S33-6. PubMed ID: 18162986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SV40 infection associated with rituximab treatment after kidney transplantation in nonhuman primates.
    Maki T; Carville A; Stillman IE; Sato K; Kodaka T; Minamimura K; Ogawa N; Kanamoto A; Gottschalk R; Monaco AP; Marr-Belvin A; Westmoreland SV; Sehgal P
    Transplantation; 2008 Mar; 85(6):893-902. PubMed ID: 18360273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection.
    Deteix C; Attuil-Audenis V; Duthey A; Patey N; McGregor B; Dubois V; Caligiuri G; Graff-Dubois S; Morelon E; Thaunat O
    J Immunol; 2010 May; 184(9):5344-51. PubMed ID: 20357253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.
    Stüve O; Cepok S; Elias B; Saleh A; Hartung HP; Hemmer B; Kieseier BC
    Arch Neurol; 2005 Oct; 62(10):1620-3. PubMed ID: 16216948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of B-cell activating factor belonging to tumor necrosis factor superfamily (BAFF) significantly correlated with C4D in kidney allograft rejection.
    Xu H; He X; Sun J; Shi D; Zhu Y; Zhang X
    Transplant Proc; 2009; 41(1):112-6. PubMed ID: 19249491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
    Ratanatharathorn V; Pavletic S; Uberti JP
    Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterisation of Tertiary Lymphoid Organs in Explanted Rejected Donor Kidneys.
    Xu X; Han Y; Wang Q; Cai M; Qian Y; Wang X; Huang H; Xu L; Xiao L; Shi B
    Immunol Invest; 2016; 45(1):38-51. PubMed ID: 26709668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
    Kaczmarek I; Deutsch MA; Sadoni S; Brenner P; Schmauss D; Daebritz SH; Weiss M; Meiser BM; Reichart B
    J Heart Lung Transplant; 2007 May; 26(5):511-5. PubMed ID: 17449422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of chronic antibody-mediated rejection with IVIG and rituximab in pediatric renal transplant recipients.
    Billing H; Rieger S; Ovens J; Süsal C; Melk A; Waldherr R; Opelz G; Tönshoff B
    Transplantation; 2008 Nov; 86(9):1214-21. PubMed ID: 19005402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of B lymphocytes (CD20+) in renal allograft biopsy specimens.
    Martins HL; Silva C; Martini D; Noronha IL
    Transplant Proc; 2007 Mar; 39(2):432-4. PubMed ID: 17362749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B cells in cluster or in a scattered pattern do not correlate with clinical outcome of renal allograft rejection.
    Scheepstra C; Bemelman FJ; van der Loos C; Rowshani AT; van Donselaar-Van der Pant KA; Idu MM; ten Berge IJ; Florquin S
    Transplantation; 2008 Sep; 86(6):772-8. PubMed ID: 18813100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren's syndrome.
    Pers JO; Devauchelle V; Daridon C; Bendaoud B; Le Berre R; Bordron A; Hutin P; Renaudineau Y; Dueymes M; Loisel S; Berthou C; Saraux A; Youinou P
    Arthritis Rheum; 2007 May; 56(5):1464-77. PubMed ID: 17469105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab for humoral rejection after kidney transplantation: an update.
    Rostaing L; Guilbeau-Frugier C; Kamar N
    Transplantation; 2009 Apr; 87(8):1261. PubMed ID: 19384176
    [No Abstract]   [Full Text] [Related]  

  • 34. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
    Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Egawa H; Ohmori K; Haga H; Tsuji H; Yurugi K; Miyagawa-Hayashino A; Oike F; Fukuda A; Yoshizawa J; Takada Y; Tanaka K; Maekawa T; Ozawa K; Uemoto S
    Liver Transpl; 2007 Apr; 13(4):579-88. PubMed ID: 17394164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy.
    Rawal YB; Nuovo GJ; Frambach GE; Porcu P; Baiocchi RA; Magro CM
    J Cutan Pathol; 2005 Oct; 32(9):616-21. PubMed ID: 16176299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloantibodies and outcomes of deceased donor kidney allografts.
    Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P
    Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD20 antibody suppresses anti-HLA antibody formation in a HLA-A2 transgenic mouse model of sensitization.
    Wu GD; He Y; Chai NN; Toyoda M; Dunn R; Kehry MR; Klein AS; Jordan SC
    Transpl Immunol; 2008 Jul; 19(3-4):178-86. PubMed ID: 18595710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy.
    Anolik JH; Barnard J; Owen T; Zheng B; Kemshetti S; Looney RJ; Sanz I
    Arthritis Rheum; 2007 Sep; 56(9):3044-56. PubMed ID: 17763423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
    Zarkhin V; Li L; Kambham N; Sigdel T; Salvatierra O; Sarwal MM
    Am J Transplant; 2008 Dec; 8(12):2607-17. PubMed ID: 18808404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.